எரிக் ஜி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article HANGZHOU, China, July 27, 2021 /PRNewswire/  On July 27, 2021, Venus Medtech (Hangzhou) Inc. ( Venus Medtech ) (stock code: 2500.HK), a leading provider of comprehensive interventional heart valve therapy solutions in China, and its controlling subsidiary Renaly Ltd., announced that Professor Martin B. Leon, MD, a pioneer in the field of interventional cardiovascular devices, has been appointed as the Global Principal Investigator (PI) for its new-generation renal artery denervation (RDN) system. (PRNewsfoto/杭州启明医疗器械股份有限公司) Dr. Leon is currently Professor of Medicine at Columbia University Irving Medical Center (CUIMC) in New York. He is also Director of the Center for Interventional Vascular Therapy (CIVT), Director of the Cardiac Catheterization Laboratories and the Director of the executive board of the New York-Presbyterian University Hospital of Columbia and Cornell Heart & Valve Center. In addition, he i

Eric ziMedtronic symplicity spyralVenus medtechVenus medtech hangzhou incWorld health organizationDrug administrationChina hypertensionMode ultrasound technologySymplicity spyralRenal denervation systemRecor medicalUltrasonic denervation systemBreakthrough device designationDual mode ultrasound technologyChina hypertension surveyExecutive director